Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Credit NIAID-RML
Highlighted Sections
Update on Bebtelovimab
This statement explains why the Panel no longer recommends bebtelovimab.
Clinical Management of Adults Summary
This section contains tables with the Panel’s recommendations for the therapeutic management of adults with COVID-19.
Prioritization of Therapeutics
The Panel offers guidance on how to prioritize patients when logistical constraints prevent remdesivir from being administered to all eligible patients.
Clinical Management of Children Summary
The tables in this section summarize the Panel’s recommendations for the therapeutic management of children with COVID-19 or MIS-C.
Overview of COVID-19
This section discusses the recent data on disparities in COVID-19-related health outcomes, access to care, and receipt of treatment among racial and ethnic minority groups.
Guidelines Development
The Panel has revised the evidence rating scheme for recommendations in the Guidelines.
Update on Bebtelovimab
This statement explains why the Panel no longer recommends bebtelovimab.
Clinical Management of Adults Summary
This section contains tables with the Panel’s recommendations for the therapeutic management of adults with COVID-19.
Prioritization of Therapeutics
The Panel offers guidance on how to prioritize patients when logistical constraints prevent remdesivir from being administered to all eligible patients.
Clinical Management of Children Summary
The tables in this section summarize the Panel’s recommendations for the therapeutic management of children with COVID-19 or MIS-C.
Overview of COVID-19
This section discusses the recent data on disparities in COVID-19-related health outcomes, access to care, and receipt of treatment among racial and ethnic minority groups.
Guidelines Development
The Panel has revised the evidence rating scheme for recommendations in the Guidelines.
Update on Bebtelovimab
This statement explains why the Panel no longer recommends bebtelovimab.
Clinical Management of Adults Summary
This section contains tables with the Panel’s recommendations for the therapeutic management of adults with COVID-19.
Prioritization of Therapeutics
The Panel offers guidance on how to prioritize patients when logistical constraints prevent remdesivir from being administered to all eligible patients.
Clinical Management of Children Summary
The tables in this section summarize the Panel’s recommendations for the therapeutic management of children with COVID-19 or MIS-C.
Overview of COVID-19
This section discusses the recent data on disparities in COVID-19-related health outcomes, access to care, and receipt of treatment among racial and ethnic minority groups.
Guidelines Development
The Panel has revised the evidence rating scheme for recommendations in the Guidelines.